Cargando…
Digital therapeutics for essential hypertension using a smartphone application: A randomized, open‐label, multicenter pilot study
Hypertension is the most considerable but treatable risk factor for cardiovascular disease. Although physicians prescribe multiple antihypertensive drugs and promote lifestyle modifications, the real‐world blood pressure (BP) control rate remains poor. To improve BP target achievement, we developed...
Autores principales: | Kario, Kazuomi, Nomura, Akihiro, Kato, Ayaka, Harada, Noriko, Tanigawa, Tomoyuki, So, Ryuhei, Suzuki, Shin, Hida, Eisuke, Satake, Kohta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678748/ https://www.ncbi.nlm.nih.gov/pubmed/33484628 http://dx.doi.org/10.1111/jch.14191 |
Ejemplares similares
-
A multicenter clinical trial to assess the efficacy of the digital therapeutics for essential hypertension: Rationale and design of the HERB‐DH1 trial
por: Kario, Kazuomi, et al.
Publicado: (2020) -
Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial
por: Kario, Kazuomi, et al.
Publicado: (2021) -
Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial
por: Nomura, Akihiro, et al.
Publicado: (2019) -
Efficacy of the Ascure Smoking Cessation Program: Retrospective Study
por: Kato, Ayaka, et al.
Publicado: (2020) -
Comparing Telemedicine and Face-to-Face Consultation Based on the Standard Smoking Cessation Program for Nicotine Dependence: Protocol for a Randomized Controlled Trial
por: Tanigawa, Tomoyuki, et al.
Publicado: (2019)